Monthly Archives:

OnabotulinumtoxinA Safe and Efficacious over 4 Years of Treatment

New Orleans—There was long-term treatment benefit among patients with neurogenic detrusor overactivity who completed 4 years of treatment with onabotulinumtoxinA (onabotA). Year-to-year, patients experienced consistent improvements in daily urinary incontinence episodes and quality of life. There were no new safety signals observed over time. Those were among the findings of a study conducted by Eric Rovner, MD, and colleagues that ... Read More »